Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms

por Ferran, Aude A., Liu, JingJing, Toutain, Pierre-Louis, Bousquet-Mélou, Alain
Publicado 2016

Veterinary Medicine Needs New Green Antimicrobial Drugs

por Toutain, Pierre-Louis, Ferran, Aude A., Bousquet-Melou, Alain, Pelligand, Ludovic, Lees, Peter
Publicado 2016

Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo Efficacie...

por Lhermie, Guillaume, El Garch, Farid, Toutain, Pierre-Louis, Ferran, Aude A., Bousquet-Mélou, Alain
Publicado 2015

Levers to Improve Antibiotic Treatment of Lambs via Drinking Water in Sheep Fattening Houses: The Example of the Sulfadimethoxine/Trimethoprim Combination

por Ferran, Aude A., Lacroix, Marlène Z., Bousquet-Mélou, Alain, Duhil, Ivain, Roques, Béatrice B.
Publicado 2020

Destruction of Staphylococcus aureus biofilms by combining an antibiotic with subtilisin A or calcium gluconate

por Liu, JingJing, Madec, Jean-Yves, Bousquet-Mélou, Alain, Haenni, Marisa, Ferran, Aude A.
Publicado 2021

Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice

por Vasseur, Maleck V., Lacroix, Marlene Z., Toutain, Pierre-Louis, Bousquet-Melou, Alain, Ferran, Aude A.
Publicado 2017

Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model

por Lallemand, Elodie Anne, Zemirline, Claudine, Toutain, Pierre-Louis, Bousquet-Melou, Alain, Ferran, Aude A., Boullier, Séverine
Publicado 2021

Biased computation of probability of target attainment for antimicrobial drugs

por Toutain, Pierre‐Louis, Gandia, Peggy, Pelligand, Ludovic, Ferran, Aude A., Lees, Peter, Bousquet‐Mélou, Alain, Concordet, Didier
Publicado 2023

In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations

por Lallemand, Elodie A., Lacroix, Marlène Z., Toutain, Pierre-Louis, Boullier, Séverine, Ferran, Aude A., Bousquet-Melou, Alain
Publicado 2016

Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus

por Broussou, Diane C., Toutain, Pierre-Louis, Woehrlé, Frédérique, El Garch, Farid, Bousquet-Melou, Alain, Ferran, Aude A.
Publicado 2019

Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude, Toutain, Pierre-Louis
Publicado 2019

The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination

por Ferran, Aude A., Lacroix, Marlène Z., Gourbeyre, Ophélie, Huesca, Alicia, Gaborieau, Baptiste, Debarbieux, Laurent, Bousquet-Mélou, Alain
Publicado 2022

Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019

Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019

Authors’ Reply to Lechat et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019

Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019

Authors’ Reply to Yu et al.: “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”

por Concordet, Didier, Gandia, Peggy, Montastruc, Jean-Louis, Bousquet-Mélou, Alain, Lees, Peter, Ferran, Aude A., Toutain, Pierre-Louis
Publicado 2019

En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach

por Toutain, Pierre-Louis, Bousquet-Mélou, Alain, Damborg, Peter, Ferran, Aude A., Mevius, Dik, Pelligand, Ludovic, Veldman, Kees T., Lees, Peter
Publicado 2017